Biotech Startups

RCE Technologies develops a wrist-worn wearable (Infrasensor) that uses infrared sensors and machine learning to detect signals associated with severe coronary artery occlusion, aiming for earlier heart attack detection. The technology targets clinical and acute care settings such as emergency departments and pre-hospital paramedic use.

1 investor

RDD Pharma is a specialty pharmaceutical company developing targeted treatments for anorectal diseases and gastrointestinal disorders, such as fecal incontinence, pruritus ani, and radiation proctitis. It repurposes already-approved drugs combined with its proprietary drug-delivery technology to shorten the regulatory path while retaining patent protection.

1 investor

Reacta Healthcare provides standardized meal products for oral food challenge testing, which is a clinical procedure used in allergy diagnosis and management.

1 investor

Reaction Biology provides drug discovery and development services for pharmaceutical companies, offering preclinical research platforms including biochemistry, in vivo efficacy testing, and patient-derived xenograft models.

1 investor

ReactWise develops AI tools for chemistry and chemical engineering, enabling researchers and engineers to accelerate molecular discovery and reaction optimization. The company combines machine learning with chemistry automation and high-throughput experimentation platforms.

1 investor

ReadoutAI offers AI tools that automatically analyze clinical trial data, running statistics and generating tables, graphs, and written summaries of the findings. Results are provided as downloadable Word or Excel files for clinical trial researchers.

1 investor

Real Life Sciences develops Natural Language Processing platforms for pharmaceutical and contract research organizations to discover novel insights from clinical and real-world data while protecting patient identity and confidential information.

1 investor

Realbio (锐翌生物) operates a human microbiome medical and gut microbiota health management business, offering a full-cycle service covering early detection, microbiota transplantation, and microbiome-based conditioning. It provides integrated solutions to medical aesthetics and health management institutions in China.

1 investor

A company that produces and sells herbal and medicinal plant products, including essential oils, plant extracts, herbal distillates, dietary supplements, disinfectants, and animal-care products. It also operates research and development units covering traditional medicine, formulation, veterinary science, and agricultural research.

1 investor

RealSeq Biosciences develops RNA fragmentomics technology to discover biomarkers for next-generation diagnostics, and sells small RNA library preparation kits and NGS sequencing services. Its products serve research and diagnostic applications such as liquid biopsies for oncology and infectious disease as well as soil sampling.

1 investor

Reapplix develops advanced wound care products and therapeutics for clinical use. The company serves healthcare systems and wound care providers in the medical device and regenerative medicine sector.

1 investor

Recall Therapeutics is a biotechnology company developing therapeutics that target biological pathways linking cognitive decline with systemic health, aiming to restore functions lost to disease and aging. Its research focuses on Alzheimer's disease, cancer-related cachexia, and age-related muscle loss.

1 investor

Reccan is a medtech company focused on improving early diagnosis and prognosis for patients with pancreatic cancer through the development of biomarker-based diagnostic tools. The company leverages decades of clinical and translational research at Lund University Hospital to address limitations in existing tumor markers.

1 investor

Recognify is a biotech company developing therapeutic and diagnostic products for CNS disease, oncology, and infectious disease. The company is led by experienced drug development and clinical executives with backgrounds across major pharmaceutical and biotech organizations.

1 investor

Adularia (Recolony) develops cancer immunotherapies based on microbiome research, using a microbial metabolite mechanism that activates tumor-residing macrophages to trigger an anti-tumor immune response. The company designs an optimized, tumor-targeted immunotherapy molecule using multi-omics and AI-driven molecule design.</parameter> <parameter name="founders">[{"full_name": "Ana Montalban-Arques", "title": "CEO & Co-Founder"}, {"full_name": "Philipp Busenhart", "title": "COO & Co-Founder"}, {"full_name": "Egl\u0117 Katkevi\u010di\u016bt\u0117", "title": "CSO & Co-Founder"}, {"full_name": "David Seeberger", "title": "CFO"}]

1 investor

Recombinetics develops gene-edited animals, offering custom gene-edited swine models for translational preclinical and biomedical research, including reporter and cancer models. It also applies gene editing to food animals to improve animal health, welfare, and sustainability in agriculture.

1 investor

Reconnect Labs develops precision neuropsychiatry approaches to treat sleep, anxiety, and addiction disorders, drawing on clinical drug development and psychiatric research. It operates in the neuropsychiatry and clinical drug development space.

1 investor

Specialty biopharmaceutical company developing differentiated prescription drugs for analgesia, anesthesia, sedation, and chronic pain management.

1 investor

Red Tree is a life science venture capital firm using a West Coast-focused, early-stage investment strategy. It backs entrepreneurs developing first-in-class or best-in-class therapeutics in oncology, neurology, and immunology.

1 investor

Red Ace is a biotech company developing cancer therapies using what it calls selection gene drive technology, delivering therapeutic gene circuits into tumor cells via tumor-targeted viral vectors. Its approach reprograms cancer cells with synthetic vulnerabilities to overcome drug resistance and work alongside existing oncology treatments.

1 investor

Redbud Labs develops microfluidics-based technology for sample preparation products. It focuses on solving complex microfluidic problems in the life sciences and diagnostics space.

1 investor

RedDress develops autologous wound healing solutions, including its ActiGraft/ActiGraftPro product that uses a patient's own blood to create a blood-derived clot for treating chronic, non-healing wounds. It sells to healthcare providers and clinicians, with products eligible for Medicare reimbursement in the U.S.

1 investor

RedShiftBio develops analytical technology that provides real-time measurement of biomolecular structure and concentration, aimed at supporting decisions in biopharmaceutical development and manufacturing.

1 investor

Redux Bio develops bio-based vaccines and biological solutions for animal health and aquaculture, including fish and other livestock products. The company focuses on early discovery, development, and scale-up of vaccines and industrial biotech products for the animal health industry.

1 investor